Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „marketing“
Suchtreffer
Begriffe & Kennungen
Actrapid · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenActrapid · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Post-marketing study in paediatric patients (H6D-JE-TD01) Safety data were collected during an observational p
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Post-marketing study in paediatric patients (H6D-JE-TD01) Safety data were collected during an observational p
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · From post-marketing experience with AS03-containing vaccines containing 3.75 microgram HA derived from A/Calif
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · Interpandemic trivalent vaccines In addition, from post-marketing surveillance with interpandemic trivalent va
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · No post-marketing surveillance data are available following Adjupanrix administration.
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · Post-marketing surveillance
Eintrag öffnenAdtralza · 4.8 · Adverse reactions observed from clinical trials and post-marketing experience are presented in Table 1 by syst
Eintrag öffnenAerinaze · 4.8 · 7 Other adverse reactions reported for desloratadine during the post-marketing period are listed hereunder.
Eintrag öffnenAerinaze · 4.8 · Other adverse reactions reported for pseudoephedrine-containing products during the post-marketing period are
Eintrag öffnenAerius · 4.8 · Paediatric population Other undesirable effects reported during the post-marketing period in paediatric patien
Eintrag öffnenAerius · 4.8 · Paediatric population Other undesirable effects reported during the post-marketing period in paediatric patien
Eintrag öffnenAfinitor · 4.8 · 13 In clinical studies and post-marketing spontaneous reports, everolimus has been associated with cases of PJ
Eintrag öffnenAfinitor · 4.8 · In clinical studies and post-marketing spontaneous reports, angioedema has been reported with and without conc
Eintrag öffnenAfinitor · 4.8 · In clinical studies and post-marketing spontaneous reports, everolimus has been associated with cases of ameno
Eintrag öffnenAfinitor · 4.8 · In clinical studies and post-marketing spontaneous reports, everolimus has been associated with renal failure
Eintrag öffnenAfinitor · 4.8 · In clinical studies and post-marketing spontaneous reports, everolimus has been associated with serious cases
Eintrag öffnenAimovig · 4.8 · In the post-marketing setting, cases of anaphylaxis and angiodoema were observed.
Eintrag öffnenAjovy · 4.8 · ADRs from clinical studies and post-marketing reports are presented according to MedDRA system organ classific
Eintrag öffnen